Found: 24
Select item for more details and to access through your institution.
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231151845
- By:
- Publication type:
- Article
The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221110162
- By:
- Publication type:
- Article
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211049779
- By:
- Publication type:
- Article
Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211018018
- By:
- Publication type:
- Article
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211049779
- By:
- Publication type:
- Article
Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211018018
- By:
- Publication type:
- Article
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920975326
- By:
- Publication type:
- Article
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920942378
- By:
- Publication type:
- Article
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920942378
- By:
- Publication type:
- Article
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919874653
- By:
- Publication type:
- Article
Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 216, doi. 10.3390/cancers15010216
- By:
- Publication type:
- Article
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 6013, doi. 10.3390/cancers14236013
- By:
- Publication type:
- Article
Extracellular Vesicles-ceRNAs as Ovarian Cancer Biomarkers: Looking into circRNA-miRNA-mRNA Code.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143404
- By:
- Publication type:
- Article
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2415, doi. 10.3390/cancers12092415
- By:
- Publication type:
- Article
Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)—Prevalence and Geographic Distribution of Pathogenic Variants in BRCA1/2 Genes.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1158, doi. 10.3390/cancers12051158
- By:
- Publication type:
- Article
Moving the Target on the Optimal Adjuvant Strategy for Resected Pancreatic Cancers: A Systematic Review with Meta-Analysis.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 534, doi. 10.3390/cancers12030534
- By:
- Publication type:
- Article
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis.
- Published in:
- Cancers, 2019, v. 11, n. 8, p. 1189, doi. 10.3390/cancers11081189
- By:
- Publication type:
- Article
Stabilizing versus Destabilizing the Microtubules: A Double-Edge Sword for an Effective Cancer Treatment Option?
- Published in:
- Analytical Cellular Pathology: Cellular Oncology, 2015, v. 2015, p. 1, doi. 10.1155/2015/690916
- By:
- Publication type:
- Article
Nintedanib in NSCLC: evidence to date and place in therapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2016, v. 8, n. 3, p. 188, doi. 10.1177/1758834016630976
- By:
- Publication type:
- Article
TTF-1/p63-Positive Poorly Differentiated NSCLC: A Histogenetic Hypothesis from the Basal Reserve Cell of the Terminal Respiratory Unit.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 1, p. 25, doi. 10.3390/diagnostics10010025
- By:
- Publication type:
- Article
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study.
- Published in:
- Oncologist, 2024, v. 29, n. 1, p. e141, doi. 10.1093/oncolo/oyad206
- By:
- Publication type:
- Article
WHAT ARE THE MULTIGENIC FINGERPRINT HALLMARKS IN TRIPLE-NEGATIVE BREAST CANCER?
- Published in:
- Journal of Biological Research / Bollettino della Società Italiana di Biologia Sperimentale, 2021, v. 94, p. 43
- By:
- Publication type:
- Article
CIRCULATING IMMUNE-CHECKPOINTS AND LYMPHOCYTE MICRORNAs IN RENAL CELL CARCINOMA AS A NOVEL BIOMARKERS OF IMMUNOTHERAPY RESPONSE.
- Published in:
- Journal of Biological Research / Bollettino della Società Italiana di Biologia Sperimentale, 2021, v. 94, p. 40
- By:
- Publication type:
- Article
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC).
- Published in:
- 2019
- By:
- Publication type:
- journal article